Journal article
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial
L Romani, M Marks, O Sokana, T Nasi, B Kamoriki, B Cordell, H Wand, MJ Whitfeld, D Engelman, AW Solomon, JM Kaldor, AC Steer
Lancet Infectious Diseases | ELSEVIER SCI LTD | Published : 2019
Open access
Abstract
Background: In small community-based trials, mass drug administration of ivermectin has been shown to substantially decrease the prevalence of both scabies and secondary impetigo; however, their effect at large scale is untested. Additionally, combined mass administration of drugs for two or more neglected diseases has potential practical advantages, but efficacy of potential combinations should be confirmed. Methods: The azithromycin ivermectin mass drug administration (AIM) trial was a prospective, single-arm, before-and-after, community intervention study to assess the efficacy of mass drug administration of ivermectin for scabies and impetigo, with coadministration of azithromycin for tr..
View full abstractGrants
Awarded by Wellcome Trust
Funding Acknowledgements
International Trachoma Initiative, Murdoch Children's Research Institute, Scobie and Claire Mackinnon Trust, and the Wellcome Trust.